Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.78 |
| ▸ | ACHE | P22303 | 9/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10951154 | 0.88 | MAOB (1.00) | MAOBACHE | |
| SCHEMBL4862874 | 0.85 | MAOB (0.72) | MAOBACHE | |
| SCHEMBL25443453 | 0.80 | MAOB (0.73) | MAOBACHE | |
| SCHEMBL14030727 | 0.79 | MAOB (1.00) | MAOBACHE | |
| SCHEMBL4606466 | 0.78 | MAOB (1.00) | MAOBACHE | |
| SCHEMBL14268966 | 0.77 | MAOB (0.57) | MAOBACHE | |
| Hydrochloric Acid SCHEMBL9373012 | 0.77 | ACHE (0.97) | MAOBACHE | |
| SCHEMBL4633333 | 0.77 | GRM5 (0.66) | TSHR | |
| SCHEMBL13590077 | 0.75 | ACHE (0.68) | MAOBACHE | |
| SCHEMBL4871016 | 0.75 | MAOB (0.58) | MAOBACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080287376-A1 | Ketolide Derivatives as Antibacterial Agents | Salman, Mohammad (US) | 2008-11-20 | — | — | US | disclosed |
| EP-1794171-A2 | KETOLIDE DERIVATIVES AS ANTIBACTERIAL AGENTS | RANBAXY LABORATORIES, LTD. (IN) | 2007-06-13 | — | — | EP | disclosed |
| WO-2006080954-A1 | KETOLIDE DERIVATIVES AS ANTIBACTERIAL AGENTS | RANBAXY LABORATORIES LIMITED (IN) | 2006-08-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287376-A1 | Ketolide Derivatives as Antibacterial Agents | MGAM, MGAM2, HEXA | MAOB 3528/4885ACHE 686/4885TSHR 3491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.